pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
the cabinet
Drugs
8,127
products tracked
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
131
view
list
cards
Marketed
plasma protein fraction (human)
Plasmanate
Hemorrhagic Shock
Grifols USA LLC
Marketed
plasminogen (human)
Ryplazim (plasminogen (human)-tvmh)
Congenital Plasminogen Deficiency
ProMetic BioTherapeutics Inc
Phase 3
plasminogen concentrate
Conjunctivitis
Kedrion SpA
Phase 3
← prev
page 245 of 271
next →
Pain
89
Neurology
1
plastoquinone decyl triphenylphosphonium bromide
Visomitin
Keratoconjunctivitis Sicca (Dry Eye)
Mitotech SA
Marketed
plazomicin sulfate
Zemdri (plazomicin sulfate)
Pyelonephritis
Cipla USA Inc
Marketed
plecanatide
Trulance (plecanatide)
Constipation
Salix Pharmaceuticals Ltd
Phase 2
plencifgene parvec
plencifgene parvec
Cystic Fibrosis
$FDMT
4D Molecular Therapeutics, Inc.
Phase 3
plinabulin
plinabulin
Febrile Neutropenia
$BYSI
BeyondSpring Inc.
Phase 2
plixorafenib
plixorafenib
Central Nervous System (CNS) Tumor
Fore Biotherapeutics Inc
Phase 2
plogosertib
plogosertib [INN]
Bladder Cancer
Tethra Biosciences Inc
Phase 3
pneumococcal conjugate (21-valent) vaccine
Pneumonia
SK Bioscience Ltd
pre_registration
pneumococcal polysaccharide [21-valent] vaccine
Capvaxive
Streptococcal Pneumonia
$MRK
Merck & Co., Inc.
Marketed
pneumococcal polysaccharide [23-valent] vaccine
Pneumovax 23
Streptococcal Pneumonia
$MRK
Merck & Co., Inc.
Marketed
pneumococcal polysaccharide [serotypes 1, 3, 4, 5, 6A, 6B, 7F, 8, 9V, 10A, 11A, 12F, 14, 15B, 18C, 19A, 19F, 22F, 23F, 33F] (20-valent) vaccine
Prevnar 20
Otitis Media
$PFE
PFIZER INC
Preclinical
pneumococcal vaccine
Streptococcal Pneumonia
Aeolian Biotech LLC
Preclinical
pneumococcal vaccine 2
Streptococcal Pneumonia
Aeolian Biotech LLC
Phase 1
pneumonic plaque vaccine
Pneumonic Plague
Wake Forest University
Phase 2
pocenbrodib hydrochloride
pocenbrodib hydrochloride
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Pathos AI Inc
Phase 2
pociredir
pociredir
Sickle Cell Disease
$FULC
Fulcrum Therapeutics, Inc.
Phase 2
podentamig
podentamig [INN]
Refractory Multiple Myeloma
$MRK
Merck & Co., Inc.
Marketed
podofilox
Condylox (podofilox)
Genital Warts (Condylomata Acuminata)
Allergan Sales LLC
Marketed
polidocanol
Varithena (polidocanol)
Varicose Veins
BTG International Inc
Phase 3
polihexanide
Akantior (polihexanide)
Parasitic (Acanthamoeba) Corneal Ulcers
SIFI SpA
Marketed
poliomyelitis [strains (Mahoney + MEF-1 + Saukett)] (trivalent) vaccine
IPOL
Poliomyelitis
Sanofi Pasteur Inc
Marketed
polymyxin B
Polymyxin B Sulfate (polymyxin B [INN])
Bacteremia
Xellia Pharmaceuticals USA LLC
Phase 2
polzastobart
polzastobart
Cutaneous Squamous Cell Carcinoma (cSCC)
Concentra Biosciences LLC
Marketed
ponatinib hydrochloride
Iclusig (ponatinib hydrochloride)
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leuk…
$TAK
TAKEDA PHARMACEUTICAL CO LTD
Marketed
ponesimod
Ponvory (ponesimod)
Ulcerative Colitis
$VNDA
Vanda Pharmaceuticals Inc.
Marketed
poractant alfa
Curosurf (poractant alfa)
Neonatal Respiratory Distress Syndrome
Chiesi USA Inc
Marketed
porfimer sodium
Photofrin (porfimer sodium)
Endobronchial Cancer
Concordia Healthcare USA Inc
